In colorectal cancer (CRC), FTO overexpression inhibits ferroptosis by upregulating SLC7A11 and GPX4, thereby promoting CRC carcinogenesis through an m6A-YTHDF2-dependent mechanism (Qiao et al., 2024). The gene discussed is YTHDF2; the disease is colorectal carcinoma.